Alison F Smith
Cited by
Cited by
PET-CT surveillance versus neck dissection in advanced head and neck cancer
H Mehanna, WL Wong, CC McConkey, JK Rahman, M Robinson, ...
New England Journal of Medicine 374 (15), 1444-1454, 2016
PET-NECK: a multicentre randomised Phase III non-inferiority trial comparing a positron emission tomography-computerised tomography-guided watch-and-wait policy with planned …
H Mehanna, CC McConkey, JK Rahman, WL Wong, AF Smith, C Nutting, ...
National Institute for Health Research, 2017
Costs of cancer care for use in economic evaluation: a UK analysis of patient-level routine health system data.
PS Hall, P Hamilton, C Hulme, D Meads, J H, N A, M J, S AF, M H, V G, ...
British Journal of Cancer, 2015
Value of information analysis of multiparameter tests for chemotherapy in early breast cancer: the OPTIMA prelim trial
PS Hall, A Smith, C Hulme, A Vargas-Palacios, A Makris, ...
Value in Health 20 (10), 1311-1318, 2017
The future for diagnostic tests of acute kidney injury in critical care: evidence synthesis, care pathway analysis and research prioritisation
PS Hall, ED Mitchell, AF Smith, DA Cairns, M Messenger, M Hutchinson, ...
Health Technology Assessment (NIHR), 2018
Cost-effectiveness analysis of PET-CT-guided management for locally advanced head and neck cancer
AF Smith, PS Hall, CT Hulme, JA Dunn, CC McConkey, JK Rahman, ...
European Journal of Cancer 85, 6-14, 2017
Results of the randomized phase IIB ARCTIC trial of low-dose rituximab in previously untreated CLL
DR Howard, T Munir, L McParland, AC Rawstron, D Milligan, A Schuh, ...
Leukemia 31 (11), 2416-2425, 2017
Early economic evaluation of diagnostic technologies: experiences of the NIHR Diagnostic Evidence Co-operatives
L Abel, B Shinkins, A Smith, A Sutton, G Sagoo, U I, J Allen, S Graziadio, ...
Medical Decision Making, 2019
Toward a Framework for Outcome-Based Analytical Performance Specifications: A Methodology Review of Indirect Methods for Evaluating the Impact of Measurement Uncertainty on …
A Smith, B Shinkins, P Hall, C Hulme, M Messenger
Clinical Chemistry, 2019
The delivery of chemotherapy at home: an evidence synthesis
M Corbett, M Heirs, M Rose, A Smith, L Stirk, G Richardson, D Swinson, ...
Health Service and Delivery Research 3 (14), 2015
Clinical effectiveness and cost-effectiveness results from the randomised, Phase IIB trial in previously untreated patients with chronic lymphocytic leukaemia to compare …
DR Howard, T Munir, L McParland, AC Rawstron, A Chalmers, ...
Health Technology Assessment (Winchester, England) 21 (28), 1-374, 2017
Setting analytical performance specifications using HbA1c as a model measurand
TP Loh, AF Smith, KJL Bell, SJ Lord, F Ceriotti, G Jones, P Bossuyt, ...
Clinica Chimica Acta 523, 407-414, 2021
The role of measurement uncertainty in health technology assessments (HTAs) of in vitro tests
AF Smith, M Messenger, P Hall, C Hulme
PharmacoEconomics 36, 823-835, 2018
Can use of the serum anti-PLA2R antibody negate the need for a renal biopsy in primary membranous nephropathy?
O Ragy, V Rautemaa, A Smith, P Brenchley, D Kanigicherla, P Hamilton
PLoS One 18 (2), e0281726, 2023
The clinical and cost effectiveness of ustekinumab for the treatment of psoriatic arthritis: a critique of the evidence
J O’Connor, S Rice, A Smith, M Rodgers, RR Lopez, D Craig, N Woolacott
PharmacoEconomics 34, 337-348, 2016
Early cost-effectiveness analysis of new medical tests: Response
AF Smith, A Sutton, B Shinkins
International journal of technology assessment in health care 32 (4), 324-325, 2016
Integrating early economic evaluation into target product profile development for medical tests: advantages and potential applications
P Cocco, MP Messenger, AF Smith, RM West, B Shinkins
International Journal of Technology Assessment in Health Care 37 (1), e68, 2021
An exploratory assessment of the impact of a novel risk assessment test on breast cancer clinic waiting times and workflow: a discrete event simulation model
AF Smith, SN Frempong, N Sharma, RD Neal, L Hick, B Shinkins
BMC Health Services Research 22 (1), 1301, 2022
Methods to assess the impact of test measurement uncertainty on downstream clinical outcomes: A case study of faecal calprotectin (FC) for the diagnosis of Inflammatory Bowel …
A Smith, B Shinkins, C Hulme, P Hall, M Messenger
Clinica Chimica Acta 493, S353-S354, 2019
Beyond the laboratory: A review of indirect methods to assess the impact of test measurement uncertainty on downstream clinical and cost outcomes
A Smith, B Shinkins, C Hulme, P Hall, M Michael
Clinica Chimica Acta 493, S353, 2019
The system can't perform the operation now. Try again later.
Articles 1–20